Prior Authorization Platform Humata Health Closes $25M Investment

Insider Brief

  • Humata Health raised $25 million, led by Blue Venture Fund and LRVHealth, to enhance its AI and automation technologies for streamlining prior authorizations in healthcare.
  • The platform serves over 42,000 physicians across 225 hospitals, automating the prior authorization process to ensure clinically appropriate care and comply with new CMS regulations.
  • Founded by Dr. Jeremy Friese, Humata Health aims to improve submission quality and reduce administrative burden for providers and payers, leveraging bi-directional EHR integrations and a proprietary AI engine.

PRESS RELEASE — WINTER PARK, Fla. /June 20, 2024— (BUSINESS WIRE) —Humata Health, the company creating frictionless prior authorizations for payers and providers with AI and automation, today announced that it closed a $25 million investment. The funding was led by Blue Venture Fund (representing the majority of BCBS plans) and LRVHealth (representing nearly 30 health systems and payers) with participation from Optum Ventures.406 Ventures, Highmark Ventures, and VentureforGood. With this funding, the company will broaden the scope of its proprietary generative AI technologies, expand its customer base with the nation’s leading healthcare providers, and begin partnering with payers and delegated entities to deliver complementary solutions that help them streamline prior authorizations.

More than 42,000 physicians at 225 hospitals across the country rely on Humata Health’s end-to-end technology to automate the manual, increasingly complicated process of prior authorizations, which often serves as an important checkpoint to ensure prescribed care is clinically appropriate. The Centers for Medicare and Medicaid Services (CMS) passed a rule that will require insurers to provide authorization decisions in 72 hours for urgent requests and seven calendar days for standard requests — which will result in increased demand for solutions from Humata.

Humata was founded in 2023 by industry veteran and serial entrepreneur, Dr. Jeremy Friese. The company has built proprietary AI to streamline prior authorization for providers and payers that it has augmented with assets purchased through acquisition and continues to expand upon for a comprehensive, end-to-end offering.

“As a physician executive at Mayo Clinic, I learned both the challenging complexities and importance of the prior authorization process. That’s why I founded Verata Health and now Humata Health to deliver a solution that combines the power of AI, automation and connectivity between payers and providers to create a frictionless process,” said Jeremy Friese, MD, Chairman and CEO of Humata Health. “With a large and growing customer base of providers already, this investment validates our vision of solving prior authorization on both sides of the proverbial fax machine. Raising this investment from strategic investors that represent some of the nation’s largest and most innovative providers and payers is a testament to our approach and rapidly accelerates our trajectory to have a positive impact for patients and the healthcare system.”

The Humata Health platform transforms the end-to-end experience of prior authorizations for providers and payers. With its proprietary database, the Humata Health AI engine employs machine learning to offer informed recommendations for crucial clinical documents that should be included to improve submission quality. As a result, payers are required to do less work and providers see improved first pass approvals. In addition, constant monitoring post-approval detects and flags changes that may lead to downstream denials and write-offs. Bi-directional integrations with the most common electronic health records (EHRs) and clinical documentation systems, and broad payer connectivity at state, regional and national levels facilitate unparallelled automation across all interactions for seamless processing.

“Highmark is excited to partner with Humata to continue their work of transforming the prior authorization process,” said Carl Daley, CFO of Highmark Health. “Their solutions help providers to focus more on patient care rather than paperwork. We are excited to see how their continued innovation will further improve the process for our providers and health plan.”

For more information about Humata Health and its AI technology, visit https://www.humatahealth.com/

About Humata Health

Humata Health creates frictionless prior authorization for providers and payers. With its proprietary artificial intelligence (AI) and automation technology, Humata Health delivers quality prior authorization submissions to help get patients the care they deserve. Humata Health is a physician-led company backed by a syndicate of strategic healthcare investors including Blue Venture Fund, LRVHealth, Optum Ventures, .406 Ventures, and Highmark Ventures. For more information, visit www.humatahealth.com.

Contacts

Media Contact:
Geoff Lopes
fama PR for Humata Health
LRVHealth@famapr.com

SOURCE

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

Gander Robotics Closes $1.1M Pre-Seed Round to Build Autonomous Search and Rescue Robots

Insider Brief Gander Robotics has raised $1.1 million in a pre-seed funding round co-led by Impellent Ventures and Underscore VC, to develop autonomous systems that

Hyundai Launches New Media Campaign, Set to Showcase Robotics at the FIFA World Cup

Insider Brief PRESS RELEASE — Hyundai Motor Company today highlighted its partnership with FIFA, alongside the unveiling of its new global campaign, “Next Starts Now,”

Amazon Acquires Swiss Robotics Company RIVR

Insider Brief Amazon has acquired Zurich-based RIVR Technologies, a developer of legged delivery robots, as the company looks to expand its efforts in physical AI

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

Subscribe today for the latest news about the AI landscape